| human | Q5 |
| P496 | ORCID iD | 0000-0003-3259-8003 |
| P108 | employer | Stanford University School of Medicine | Q4115969 |
| P734 | family name | John | Q5281981 |
| John | Q5281981 | ||
| John | Q5281981 | ||
| P735 | given name | Esther | Q837839 |
| Esther | Q837839 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q64115284 | 10-year performance of four models of breast cancer risk: a validation study |
| Q36016386 | 11q13 is a susceptibility locus for hormone receptor positive breast cancer |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q43425843 | 5-lipoxygenase and 5-lipoxygenase-activating protein gene polymorphisms, dietary linoleic acid, and risk for breast cancer |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q94683498 | A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry |
| Q40597341 | A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q34211808 | A comprehensive examination of breast cancer risk loci in African American women |
| Q33731355 | A functionally significant SNP in TP53 and breast cancer risk in African-American women |
| Q37109758 | A genome-wide association study of breast cancer in women of African ancestry |
| Q29417036 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. |
| Q92937384 | A genome-wide association study of prostate cancer in Latinos |
| Q35889669 | A genome-wide linkage study of mammographic density, a risk factor for breast cancer |
| Q34611972 | A genome-wide scan for breast cancer risk haplotypes among African American women |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q30416161 | A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry |
| Q35248192 | A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q36477652 | A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q36152991 | A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers |
| Q47919650 | A pilot study on the utility of reduced urine collection frequency protocols for the assessment of reproductive hormones in adolescent girls |
| Q39982410 | A qualitative study evaluating parental attitudes towards the creation of a female youth cohort (LEGACY) in the Breast Cancer Family Registry |
| Q37981608 | A review of cancer in U.S. Hispanic populations |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q43985011 | A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African Americans |
| Q36043159 | ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry |
| Q92102602 | Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool |
| Q36173722 | Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer |
| Q37271961 | Admixture Mapping of African-American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes |
| Q35080445 | Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. |
| Q35856257 | Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas |
| Q33450573 | Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. |
| Q34447543 | Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study |
| Q99545000 | African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q58613780 | Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC) |
| Q91618412 | Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium |
| Q40195005 | Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study |
| Q30779634 | Alcohol consumption and survival after a breast cancer diagnosis: a literature-based meta-analysis and collaborative analysis of data for 29,239 cases |
| Q37437960 | An admixture scan in 1,484 African American women with breast cancer |
| Q46063050 | An inverse association between ovarian cysts and breast cancer in the breast cancer family registry |
| Q45930391 | Androgen receptor and prostate-specific antigen gene polymorphisms and breast cancer in African-American women. |
| Q37315498 | Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study |
| Q35242849 | Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q64940233 | Assessing patient readiness for personalized genomic medicine. |
| Q57305944 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q38776757 | Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study |
| Q91271723 | Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness |
| Q64112402 | Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer |
| Q36178189 | Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. |
| Q37268494 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q35957703 | Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer |
| Q46409708 | Associations between ALDH1A1 polymorphisms, alcohol consumption, and mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the Breast Cancer Health Disparities Study |
| Q35527962 | Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study |
| Q35619090 | Associations between CYP19A1 polymorphisms, Native American ancestry, and breast cancer risk and mortality: the Breast Cancer Health Disparities Study |
| Q36870645 | Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study |
| Q33869600 | Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q35532898 | Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q37386163 | Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study |
| Q36792641 | Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation |
| Q63966080 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q64118820 | Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci |
| Q33927874 | Availability and accuracy of medical record information on language usage of cancer patients from a multi-ethnic population |
| Q37416050 | BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research |
| Q34571646 | BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. |
| Q37002955 | BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers |
| Q42506232 | BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays |
| Q30423088 | Body mass index and risk of second primary breast cancer: the WECARE Study |
| Q37430003 | Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer |
| Q34972027 | Body size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities study |
| Q36913430 | Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study |
| Q50046604 | Breast Cancer Family History and Allele-Specific DNA Methylation in the Legacy Girls Study. |
| Q57420847 | Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study |
| Q57265621 | Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study |
| Q46167081 | Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations |
| Q33955302 | Breast cancer incidence patterns among California Hispanic women: differences by nativity and residence in an enclave |
| Q35609710 | Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry |
| Q37410693 | Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q36449203 | CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer |
| Q59789681 | CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study |
| Q35603160 | Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype |
| Q39002074 | Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry |
| Q36683188 | Cigarette Smoking and Breast Cancer Risk in Hispanic and Non-Hispanic White Women: The Breast Cancer Health Disparities Study |
| Q37219731 | Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC) |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q36839777 | Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q34394665 | Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction |
| Q35889575 | Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. |
| Q33742096 | Common genetic variants and modification of penetrance of BRCA2-associated breast cancer |
| Q36393232 | Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers |
| Q35870067 | Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q37434133 | Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q104263819 | Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort |
| Q31082788 | Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q37047463 | Comparison of Clinical, Maternal, and Self Pubertal Assessments: Implications for Health Studies |
| Q52579925 | Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer. |
| Q34181322 | Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer |
| Q35029565 | Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry |
| Q36395280 | Contribution of the neighborhood environment and obesity to breast cancer survival: the California Breast Cancer Survivorship Consortium |
| Q57266620 | Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer |
| Q57278898 | Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) |
| Q34084261 | Correlation of DNA methylation levels in blood and saliva DNA in young girls of the LEGACY Girls study |
| Q21144874 | DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers |
| Q35911581 | Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC) |
| Q33588213 | Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers |
| Q34145554 | Diet and lifestyle factors interact with MAPK genes to influence survival: the Breast Cancer Health Disparities Study |
| Q34359953 | Diet and lifestyle factors modify immune/inflammation response genes to alter breast cancer risk and prognosis: the Breast Cancer Health Disparities Study |
| Q36341190 | Diet quality of cancer survivors and noncancer individuals: Results from a national survey |
| Q46515439 | Dietary fat, cooking fat, and breast cancer risk in a multiethnic population |
| Q38927282 | Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry |
| Q30252516 | Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium. |
| Q40060771 | Discovery of mutations in homologous recombination genes in African-American women with breast cancer |
| Q36288541 | Early-life factors and breast cancer risk in Hispanic women: the role of adolescent body size |
| Q53770189 | Energy homeostasis genes and breast cancer risk: The influence of ancestry, body size, and menopausal status, the breast cancer health disparities study. |
| Q36803979 | Energy homeostasis genes and survival after breast cancer diagnosis: the Breast Cancer Health Disparities Study |
| Q30432415 | Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium |
| Q64114291 | Enrollment and biospecimen collection in a multiethnic family cohort: the Northern California site of the Breast Cancer Family Registry |
| Q37367221 | Epidermal growth factor receptor (EGFR) polymorphisms and breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study |
| Q40781176 | Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study |
| Q33780831 | European ancestry is positively associated with breast cancer risk in Mexican women |
| Q37307773 | Evaluating breast cancer risk projections for Hispanic women |
| Q35883587 | Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry |
| Q33614244 | Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q33863235 | Exploring the link between MORF4L1 and risk of breast cancer |
| Q37308563 | Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry |
| Q36971965 | Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers |
| Q36087170 | Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers |
| Q36856343 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression |
| Q55380382 | Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q35389444 | Fine-mapping of breast cancer susceptibility loci characterizes genetic risk in African Americans |
| Q55311842 | Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. |
| Q35097143 | Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer |
| Q43427398 | Fish intake, cooking practices, and risk of prostate cancer: results from a multi-ethnic case-control study |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q34716723 | Generalizability of established prostate cancer risk variants in men of African ancestry |
| Q37277056 | Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area |
| Q37173291 | Genetic ancestry and risk of breast cancer among U.S. Latinas |
| Q37436758 | Genetic ancestry and risk of mortality among U.S. Latinas with breast cancer |
| Q37065332 | Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women |
| Q35999323 | Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study |
| Q37739048 | Genetic modifiers of CHEK2*1100delC-associated breast cancer risk |
| Q52561250 | Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. |
| Q35815439 | Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry |
| Q37610843 | Genetic variants and non-genetic factors predict circulating vitamin D levels in Hispanic and non-Hispanic White women: the Breast Cancer Health Disparities Study |
| Q33811527 | Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation |
| Q34009975 | Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study |
| Q39373193 | Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry |
| Q35022825 | Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q35524233 | Genetic variation in IGFBP2 and IGFBP5 is associated with breast cancer in populations of African descent |
| Q36841890 | Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study |
| Q36402013 | Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population |
| Q34204163 | Genetic variation in the JAK/STAT/SOCS signaling pathway influences breast cancer-specific mortality through interaction with cigarette smoking and use of aspirin/NSAIDs: the Breast Cancer Health Disparities Study |
| Q30000080 | Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent |
| Q36842233 | Genome-wide association analysis identifies three new breast cancer susceptibility loci |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q40346126 | Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for oestrogen receptor negative breast cancer |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q27008356 | Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk |
| Q37045108 | Genome-wide association study of age at menarche in African-American women |
| Q34375940 | Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q35009643 | Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. |
| Q28655044 | Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture |
| Q59756250 | Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer |
| Q36278329 | Germline mutations in PALB2 in African-American breast cancer cases |
| Q34643959 | Global DNA methylation levels in girls with and without a family history of breast cancer |
| Q36640906 | Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent |
| Q35382206 | Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q33709421 | Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California |
| Q35713044 | History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship Consortium |
| Q33919320 | Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population |
| Q34522623 | Human subjects protection: an event monitoring committee for research studies of girls from breast cancer families |
| Q30252854 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer |
| Q29417155 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array |
| Q39321320 | Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
| Q90091185 | Identification of novel breast cancer susceptibility loci in meta-analyses conducted among Asian and European descendants |
| Q61448654 | Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas |
| Q29417022 | Identification of seven new prostate cancer susceptibility loci through a genome-wide association study |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q31036626 | Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry |
| Q53708209 | Impact of individual and neighborhood factors on disparities in prostate cancer survival. |
| Q33599178 | Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: the Neighborhood and Breast Cancer Study |
| Q36384545 | Impact of neighborhoods and body size on survival after breast cancer diagnosis |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q37410472 | Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women |
| Q53698864 | Intake of bean fiber, beans, and grains and reduced risk of hormone receptor-negative breast cancer: the San Francisco Bay Area Breast Cancer Study. |
| Q36065460 | Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions |
| Q36249029 | Interaction between common breast cancer susceptibility variants, genetic ancestry, and nongenetic risk factors in Hispanic women |
| Q34081324 | Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer |
| Q36235844 | Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer |
| Q36897623 | Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry |
| Q46504474 | Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study. |
| Q35576848 | Lifetime physical activity and risk of endometrial cancer |
| Q43843244 | Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction |
| Q35670157 | MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study |
| Q31043651 | Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. |
| Q36998162 | Mammographic density and breast cancer: a comparison of related and unrelated controls in the Breast Cancer Family Registry |
| Q34733697 | Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study |
| Q52691048 | Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies. |
| Q34180885 | Meat consumption, cooking practices, meat mutagens, and risk of prostate cancer |
| Q38463411 | Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q89738967 | Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities study |
| Q33649334 | Meta-analysis of loci associated with age at natural menopause in African-American women |
| Q55216953 | Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry. |
| Q30977635 | Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults |
| Q46040892 | Migration history, acculturation, and breast cancer risk in Hispanic women |
| Q35576887 | Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women |
| Q30491647 | Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium |
| Q42038345 | Multiple regions within 8q24 independently affect risk for prostate cancer |
| Q49024646 | Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. |
| Q34325031 | Neighborhood influences on recreational physical activity and survival after breast cancer |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q44122211 | No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years |
| Q37628084 | Non-invasive optical spectroscopic monitoring of breast development during puberty |
| Q37396186 | Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium |
| Q46492944 | Obesity before age 30 years and risk of advanced prostate cancer |
| Q52604554 | Obesity, Body Composition, and Breast Cancer: An Evolving Science. |
| Q34398269 | Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations |
| Q36280191 | Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers |
| Q34964253 | Overall and abdominal adiposity and premenopausal breast cancer risk among hispanic women: the breast cancer health disparities study |
| Q34061135 | Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry |
| Q35737888 | Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) |
| Q37252756 | Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry |
| Q44539407 | Phytoestrogen intake and endometrial cancer risk |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36401990 | Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer |
| Q40478488 | Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study. |
| Q37353677 | Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry |
| Q36356727 | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q36494254 | Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network |
| Q45970196 | Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. |
| Q46576514 | Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups |
| Q39076835 | Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women |
| Q37103045 | Prostate Cancer Susceptibility in Men of African Ancestry at 8q24 |
| Q37149567 | Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study |
| Q37149228 | Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer |
| Q33781466 | Pubertal development in girls by breast cancer family history: the LEGACY girls cohort |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q92831625 | Quantitative Ultrasound Spectroscopy for Differentiation of Hepatocellular Carcinoma from At-Risk and Normal Liver Parenchyma |
| Q34540638 | RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study |
| Q93130677 | Race/Ethnicity and Accuracy of Self-Reported Female First-Degree Family History of Breast and Other Cancers in the Northern California Breast Cancer Family Registry |
| Q36197983 | Racial and ethnic differences in adjuvant hormonal therapy use. |
| Q36273231 | Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective |
| Q46068528 | Racial/Ethnic Differences in the Impact of Neighborhood Social and Built Environment on Breast Cancer Risk: The Neighborhoods and Breast Cancer Study |
| Q104564161 | Racial/ethnic disparities in survival after breast cancer diagnosis by estrogen and progesterone receptor status: A pooled analysis |
| Q28652308 | Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study |
| Q28652056 | Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers |
| Q35608690 | Rare variants in the ATM gene and risk of breast cancer |
| Q37373918 | Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer |
| Q28743906 | Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study |
| Q33693138 | Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004. |
| Q90439909 | Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk |
| Q24614203 | Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case-control study |
| Q36767427 | Red meat, poultry, and fish intake and breast cancer risk among Hispanic and Non-Hispanic white women: The Breast Cancer Health Disparities Study |
| Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
| Q64101959 | Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study |
| Q45953705 | Reply to Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry-methodological issues. |
| Q36415317 | Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study |
| Q48250088 | Reproductive history, breast-feeding and risk of triple negative breast cancer: The Breast Cancer Etiology in Minorities (BEM) study. |
| Q36089820 | Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study |
| Q46110960 | Residential sunlight exposure is associated with a decreased risk of prostate cancer |
| Q40396801 | Response to Conner et al. Re: "Cigarette Smoking and Breast Cancer Risk in Hispanic and Non-Hispanic White Women: The Breast Cancer Health Disparities Study". |
| Q35750765 | Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry |
| Q30415050 | Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study |
| Q37085786 | Risk of pancreatic cancer in breast cancer families from the breast cancer family registry |
| Q38717239 | Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers |
| Q35053599 | SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study |
| Q35983751 | Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry |
| Q37289611 | Second primary breast cancer occurrence according to hormone receptor status |
| Q38488106 | Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada |
| Q29417074 | Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q37353501 | Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California |
| Q46001274 | Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. |
| Q45951066 | Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. |
| Q34426763 | Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer |
| Q37085141 | Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study |
| Q37122297 | Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers |
| Q37252497 | Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study |
| Q24806109 | The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer |
| Q44897750 | The CHEK2*1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry |
| Q33716455 | The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival |
| Q37059764 | The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q64116004 | The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With or Mutations |
| Q39117896 | The Interaction between Genetic Ancestry and Breast Cancer Risk Factors among Hispanic Women: The Breast Cancer Health Disparities Study |
| Q37686870 | The LEGACY Girls Study: Growth and Development in the Context of Breast Cancer Family History |
| Q52642368 | The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study. |
| Q64998464 | The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium. |
| Q37624119 | The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF-β-signaling pathway: The Breast Cancer Health Disparities Study |
| Q30428393 | The landscape of recombination in African Americans |
| Q33686851 | The potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data |
| Q35476902 | The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry |
| Q36142060 | The role of genetic breast cancer susceptibility variants as prognostic factors |
| Q43110417 | Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study |
| Q33654997 | Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q35032730 | Validation of genome-wide prostate cancer associations in men of African descent |
| Q40075923 | Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC). |
| Q30416002 | Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population |
| Q33855441 | Whole-genome amplification enables accurate genotyping for microarray-based high-density single nucleotide polymorphism array |
Search more.